Monkey model of Parkinson's disease.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000328:Adult; D000818:Animals; D002415:Cats; D004195:Disease Models, Animal; D000882:Haplorhini; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000503:physiopathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects*; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology; D013552:Swine
D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine